Detalles de la búsqueda
1.
Brief Report: Risk of Recurrent Interstitial Lung Disease From Osimertinib Versus Erlotinib Rechallenge After Symptomatic Osimertinib-Induced Interstitial Lung Disease.
JTO Clin Res Rep
; 5(4): 100648, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38590729
2.
Efficacy of endoscopy in assessing the local disease response in nasopharyngeal carcinoma patients after treated with intensity-modulated radiotherapy.
Asia Pac J Clin Oncol
; 15 Suppl 6: 14-19, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31642178
Resultados
1 -
2
de 2
1
Próxima >
>>